A well-being support program for patients with severe mental illness: A service evaluation

BMC Psychiatry

Volumn 11, Issue , 2011, Pages

  Eldridge, Donna ^a   Dawber, Nicky ^a   Gray, Richard ^b  

^a KENT AND MEDWAY NHS AND SOCIAL CARE PARTNERSHIP TRUST   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BENZODIAZEPINE; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; ZUCLOPENTHIXOL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BIPOLAR DISORDER; BODY MASS; CARDIOVASCULAR RISK; DIET; FEMALE; HEALTH; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH CARE PERSONNEL; MENTAL HEALTH SERVICE; MENTAL PATIENT; OBESITY; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PSYCHOLOGICAL WELL BEING; SELF ESTEEM; SMOKING; SUBSTANCE ABUSE; WELL BEING SUPPORT PROGRAM; CARDIOVASCULAR DISEASE; EVALUATION; HEALTH CARE QUALITY; LIFESTYLE; MIDDLE AGED; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; RISK FACTOR; RISK REDUCTION; SATISFACTION; SELF CONCEPT;

ADULT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LIFE STYLE; MALE; MENTAL DISORDERS; MIDDLE AGED; OVERWEIGHT; PATIENT SATISFACTION; PERSONAL SATISFACTION; PROGRAM EVALUATION; RISK FACTORS; RISK REDUCTION BEHAVIOR; SELF CONCEPT;

EID: 79953091380     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-11-46     Document Type: Article

References (29)

1. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman EM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT, Friedman A, Kleinberg D, Yevich SJ, Davis B, Shon S. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004, 161:1334-1449. 10.1176/appi.ajp.161.8.1334, 15285957.
2. Newman SC, Bland RC. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psychiatry 1991, 36:239-245.
3. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000, 177:212-217. 10.1192/bjp.177.3.212, 11040880.
4. Enger C, Weatherby L, Reynolds RF, Glasser DB, Walker AM. Serious cardiovascular events and mortality among patients with schizophrenia. J Nerv Ment Dis 2004, 192:19-27. 10.1097/01.nmd.0000105996.62105.07, 14718772.
5. Haupt DW, Newcomer JW. Hyperglycemia and antipsychotic medications. J Clin Psychiatry 2001, 62(Suppl 27):15-26.
6. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005, 150:1115-1121. 10.1016/j.ahj.2005.02.007, 16338246.
7. Robson D, Gray R. Serious mental illness and physical health problems: a discussion paper. Int J Nurs Stud 2007, 44:457-466. 10.1016/j.ijnurstu.2006.07.013, 17007859.
8. Kurzthaler I, Fleischhacker WW. The clinical implications of weight gain in schizophrenia. J Clin Psychiatry 2001, 62(Suppl 7):32-37.
9. Barnes T, Paton C, Cavanagh M-R, Hancock E, Taylor DM. A UK audit of screening for the metabolic side effects of antipsychotics in community patients. Schiz Bull 2007, 33:1397-1403.
10. Burns T, Cohen A. Item-of-service payments for general practitioner care of severely mentally ill persons: does the money matter?. Br J Gen Pract 1998, 48:1415-1416. 1313136, 9800401.
11. Kendrick T. Cardiovascular and respiratory risk factors and symptoms among general practice patients with long-term mental illness. Brit J Psychiatry 1996, 169:733-739.
12. Lykouras L, Douzenis A. Do psychiatric departments in general hospitals have an impact on the physical health of mental patients?. Curr Opin Psychiatry 2008, 21:398-402. 10.1097/YCO.0b013e32830079d0, 18520746.
13. Smith S, Yeomans D, Bushe CJ, Eriksson C, Harrison T, Holmes R, Mynors-Wallis L, Oatway H, Sullivan G. A well-being programme in severe mental illness. Baseline findings in a UK cohort. Int J Clin Prac 2007, 61:1971-1978.
14. A cross-sectional survey of mental health nurses' attitudes, confidence and practice in caring for the physical health needs of people with serious mental illness. , http://www.iop.kcl.ac.uk/departments/?locator=436&project=10222.2009
15. Tosh R, Clifton A, Mala S, Bachner M. Physical health care monitoring for people with serious mental illness. Cochrane Database of Systematic Reviews 2010, 3:CD008298.
16. Millar HL. Development of a health screening clinic. European Psychiatry 2010, 25:S29-S33. 10.1016/S0924-9338(10)71703-X, 20620883.
17. Shuel F, White J, Jones M, Gray R. Using the serious mental illness health improvement profile [HIP] to identify physical problems in a cohort of community patients: a pragmatic case series evaluation. International Journal of Nursing Studies 2010, 47:136-145. 10.1016/j.ijnurstu.2009.06.003, 19596322.
18. Ball P, Coons VB, Buchanan RW. A program for treating olanzapine-related weight gain. Psychiatric Services 2001, 52(7):967-969. 10.1176/appi.ps.52.7.967, 11433117.
19. Pendlebury J, Bushe C, Wildgust H, Holt RI. Long-term maintenance of weight loss in patients with severe mental illness through a behavioural programme in UK. Acta Psychiatrica Scandinivica 2007, 115:286-294.
20. Ohlsen RI, Peacock G, Smith S. Developing a service to monitor and improve physical health in people with serious mental illness. Journal of Psychiatric and Mental Health Nursing 2005, 12:614-619. 10.1111/j.1365-2850.2005.00884.x, 16164514.
21. Smith S, Yeomans D, Bushe C, Eriksson C, Harrison T, Holmes R, Mynors-Wallis L, Oatway H, Sullivan G. A well-being programme in severe mental illness. Reducing risk for physical ill-health: A post programme service evaluation at 2 years. Eur Psychiatry 2007, 22:413-418. 10.1016/j.eurpsy.2007.07.002, 17765483.
22. Alcohol advice. , http://www.dh.gov.uk/en/Publichealth/Healthimprovement/Alcoholmisuse/DH_085385
23. Haddad P. Weight change with atypical antipsychotics in the treatment of schizophrenia. J Psychopharmacology 2005, 19(Suppl 6):16-27.
24. Pack S. Poor physical health and mortality in patients with schizophrenia. Nurs Stand 2009, 23:41-45.
25. Gray R, Brewin E, Noak J, Wyke-Joseph J, Sonik B. A review of the literature on HIV infection: implications for research, policy and clinical practice. J Psychiatr Ment Health Nurs 2002, 9:405-410. 10.1046/j.1365-2850.2002.00511.x, 12164902.
26. Friedlander AH, Marder SR. The psychopathology, medical management and dental implications of schizophrenia. J Am Dent Assoc 2002, 133:603-610.
27. McCreadie RG, Stevens H, Henderson J, Hall D, McCaul R, Filik R, Young G, Sutch G, Kanagaratnam G, Perrington S, McKendrick J, Stephenson D, Burns T. The dental health of people with schizophrenia. Acta Psychiatr Scand 2004, 110:306-310. 10.1111/j.1600-0447.2004.00373.x, 15352933.
28. Persson K, Axtelius B, Söderfeldt B, Ostman M. Monitoring oral health and dental attendance in an outpatient psychiatric population. J Psychiatr Ment Health Nurs 2009, 16:263-271. 10.1111/j.1365-2850.2008.01364.x, 19291155.
29. Shahzad S, Suleman MI, Shahab H, Mazour I, Kaur A, Rudzinskiy P, Lippmann S. Cataract occurrence with antipsychotic drugs. Psychosomatics 2002, 43:354-359. 10.1176/appi.psy.43.5.354, 12297603.